Newsroom – Europabio

PRESS RELEASES

European Biotech Week 2022 starts today!
25/09/2022
Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework
21/09/2022
Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet
21/09/2022

NEWS

25/09/2022
European Biotech Week 2022 starts today!
Read more
21/09/2022
EuropaBio sat down with new Member Freget Glaser & Associés, to learn more about investment and growth opportunities for European biotechnology
Read more
21/09/2022
Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework
Read more

25/09/2022

25/09/2022

European Biotech Week 2022 starts today!

21/09/2022

21/09/2022

EuropaBio sat down with new Member Freget Glaser & Associés, to learn more about investment and growth opportunities for European biotechnology

21/09/2022

21/09/2022

Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework

21/09/2022

21/09/2022

EuropaBio sat down with new Member Bon Vivant, to learn more about the future of alternative dairy proteins

21/09/2022

21/09/2022

Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet

21/09/2022

21/09/2022

Factsheet – Sustainable Investment and the EU Bioeconomy

19/09/2022

19/09/2022

Biotech SMEs are the heart of Europe’s healthcare ecosystem – hear their voice.

14/09/2022

14/09/2022

Registration is open to the main events of the 10th edition of the European Biotech Week

09/09/2022

09/09/2022

The Essential Role of Enzymes | The unintended impact of the REACH revision on Enzymes – and consequences for EU Green Deal Objectives

08/09/2022

08/09/2022

The role of enzymes as key enablers in the green transition and in enabling the European Commission’s sustainability ambitions in the EU Taxonomy and Sustainable Finance

07/09/2022

07/09/2022

EuropaBio response to the public consultation on the proposal for a Regulation on substances of human origin (SoHO)

07/09/2022

07/09/2022

Advanced therapy medicinal products: SMEs call for a better investment environment in Europe

07/09/2022

07/09/2022

Factsheet – Increased regulatory efficiency; what we need for the next generation of medicine

07/09/2022

07/09/2022

Factsheet – European Health Data Space

07/09/2022

07/09/2022

Factsheet – A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

07/09/2022

07/09/2022

Factsheet – A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe

29/07/2022

29/07/2022

Towards an accurate accounting for carbon from biomass in the Product Environmental Footprint (PEF)

27/07/2022

27/07/2022

EuropaBio position on the European Health Data Space proposal

18/07/2022

18/07/2022

EuropaBio Statement on the proposal for a Regulation on substances of human origin (SoHO)

13/07/2022

13/07/2022

Recombinant DNA in fermentation products is of no regulatory relevance

13/07/2022

13/07/2022

EuropaBio sat down with new Member Phytolon, to learn more about the future of natural food colours

13/07/2022

13/07/2022

Phytolon joins EuropaBio: natural food colours for better health and environmental sustainability

07/07/2022

07/07/2022

EuropaBio Statement on the publication of the New European Innovation Agenda

06/07/2022

06/07/2022

Value of Biotech

29/06/2022

29/06/2022

EuropaBio’s Vision for Europe: Innovation, Investment, Excellence

27/06/2022

27/06/2022

Unlocking the Promise of Gene Therapy

24/06/2022

24/06/2022

Considering microorganisms and New Genomic Techniques: on the need for a new GMO legislation in the European Union

23/06/2022

23/06/2022

DSM’s Patricia Malarkey appointed as new Chair of EuropaBio

20/06/2022

20/06/2022

Seizing opportunities for continued innovation, investment, and excellence in orphan medicines in Europe

15/06/2022

15/06/2022

EFIB 2022 Start-up Village: applications are open!

13/06/2022

13/06/2022

EuropaBio’s Claire Skentelbery elected as new Vice-chair of ICBA

09/06/2022

09/06/2022

EuropaBio Response to the publication of the Bioeconomy Strategy Progress Report

08/06/2022

08/06/2022

EuropaBio participates at the BIO International Convention 2022 in San Diego

25/05/2022

25/05/2022

European Week Against Cancer 2022 – Interview with Santiago Aguirre, Market Lead Europe Oncology, Sanofi

23/05/2022

23/05/2022

Big Changes Start Small

23/05/2022

23/05/2022

Jamie Wilkinson new Healthcare Biotechnology Director at EuropaBio

16/05/2022

16/05/2022

EuropaBio Statement on the Evaluation of the Cross-Border Healthcare Directive

12/05/2022

12/05/2022

A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe

27/04/2022

27/04/2022

EuropaBio SME BioForum: a new voice for the biotechnology SME community in Europe

25/04/2022

25/04/2022

Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

24/04/2022

24/04/2022

EuropaBio published policy recommendations for the healthcare and industrial biotechnology sectors

11/04/2022

11/04/2022

Registration is now open for #EFIB2022: benefit from the early bird fee

05/04/2022

05/04/2022

Become a partner of European Biotech Week 2022

04/04/2022

04/04/2022

EuropaBio NAC Summit 2022: key recommendations on how National associations can deliver Europe’s innovation, investment and excellence in biotechnology

16/03/2022

16/03/2022

EuropaBio response to the Call for Evidence on Soil health – protecting, sustainably managing and restoring EU soils

11/03/2022

11/03/2022

EuropaBio Statement on the Russian Invasion of Ukraine

08/03/2022

08/03/2022

EuropaBio National Associations Council Summit 2022: modernised regulation and legislation will deliver the potential of European biotechnology

28/02/2022

28/02/2022

EuropaBio Statement on Rare Disease Day

22/02/2022

22/02/2022

EuropaBio sat down with new Member Remilk, to learn more about the future of sustainable food production

22/02/2022

22/02/2022

Remilk joins EuropaBio: recreating dairy that makes the world a better place

21/02/2022

21/02/2022

Interview with Claire Skentelbery, Director General, EuropaBio on the 15th Edition of the European Forum for Industrial Biotechnology and the Bioeconomy (EFIB)

17/02/2022

17/02/2022

EuropaBio signs EU Code of Conduct

01/02/2022

01/02/2022

EuropaBio National Associations Council Summit 2022 (French Presidency): how does biotechnology deliver the Industrial strategy across sectors?

31/01/2022

31/01/2022

EuropaBio becomes a partner of a new European partnership for health

24/01/2022

24/01/2022

SAVE THE DATE: EFIB 2022 goes to Vilnius, Lithuania

22/12/2021

22/12/2021

EuropaBio: Revision of the EU general pharmaceuticals legislation for a healthier tomorrow

15/12/2021

15/12/2021

EuropaBio sat down with new member AB Enzymes, to find out about their highly customizable enzymes solutions

15/12/2021

15/12/2021

EuropaBio sat down with new member MabDesign, to find out about its work with the French biopharmaceutical industry

14/12/2021

14/12/2021

AB Enzymes joins EuropaBio: Individual Enzyme Solutions for Individual Requirements

14/12/2021

14/12/2021

MabDesign joins EuropaBio: innovation linked to the industrial field of biotherapy

13/12/2021

13/12/2021

Interview with Ingmar Hoerr, CureVac Founder and holder of the first patents associated with mRNA

01/12/2021

01/12/2021

EuropaBio sat down with new member ProductLife, to find out about their long-term goals Interview with… Xavier Duburcq, CEO at ProductLife Group

01/12/2021

01/12/2021

ProductLife joins EuropaBio: improving human health by delivering regulatory compliance services for the safe and effective use of medical solutions

01/12/2021

01/12/2021

EUBA position on the JRC LCA Methodology

22/11/2021

22/11/2021

The review of the general pharmaceutical legislation: an opportunity that should not be missed?

08/11/2021

08/11/2021

What is the use of innovation if it cannot be implemented? Or why consumers have the last word

03/11/2021

03/11/2021

EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform

03/11/2021

03/11/2021

Olon joins EuropaBio – Quality and Sustainability: A Modern Industrial Vision that Starts from Respect and Protection of the Environment

27/10/2021

27/10/2021

EuropaBio Comments on the Roadmap on a Policy Framework on Biobased, Biodegradable and Compostable Plastics

26/10/2021

26/10/2021

EuropaBio response to the public consultation on the roadmap on Sustainable Food Systems

26/10/2021

26/10/2021

Healthy Planet, Healthy People: a Pathway for Green Transition in the Biopharmaceutical Ecosystem

22/10/2021

22/10/2021

EuropaBio Response to the Inception Impact Assessment for Legislation for Plants Produced from Certain New Genomic Techniques (NGTs)

20/10/2021

20/10/2021

EuropaBio sat down with new Member Puratos, to find out the secret behind their centenary success

20/10/2021

20/10/2021

Puratos joins EuropaBio: Striving to Offer Healthier Solutions Every Day

19/10/2021

19/10/2021

EuropaBio Patient Bio-Forum: challenges and future potential of European Reference Networks

18/10/2021

18/10/2021

European Biotech Week 2021: Telling the stories of European Biotechnology

14/10/2021

14/10/2021

EuropaBio sat down with new Member IFF, to find out about their focus on health and well-being, product performance, and user satisfaction

14/10/2021

14/10/2021

IFF joins EuropaBio: Applying Science and Creativity for a Better World

07/10/2021

07/10/2021

#EFIB2021: Industry sets up the Business vision to deliver Green Deal ambitions

07/10/2021

07/10/2021

EFIB Vienna Statement 2021

06/10/2021

06/10/2021

#EFIB2021: Industrial Biotechnology in the business spotlight for EU Green Deal

04/10/2021

04/10/2021

EuropaBio Comments on the Roadmap on Restoring Sustainable Carbon Cycles

30/09/2021

30/09/2021

Artificial intelligence: investing in new technologies in healthcare

27/09/2021

27/09/2021

Europe celebrates life science with European Biotech Week 2021

08/09/2021

08/09/2021

Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies

27/08/2021

27/08/2021

EuropaBio response to the Public consultation on European bioeconomy policy: stocktaking and future developments

10/08/2021

10/08/2021

EuropaBio comments on the public consultation on blue bioeconomy

02/08/2021

02/08/2021

EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics

29/07/2021

29/07/2021

EuropaBio response to the Public Consultation ‘Digital Health Data and Services – The European Health Data Space’

26/07/2021

26/07/2021

EuropaBio response to the European Commission Public Consultation on the Regulation for Orphan Medicinal Products and Paediatrics: the value brought by the technology to patients and society should be well recognised

22/07/2021

22/07/2021

Call for tender: EuropaBio requires Maintenance and Development Services for its four Websites

20/07/2021

20/07/2021

EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

03/07/2021

03/07/2021

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

29/06/2021

29/06/2021

A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property

29/06/2021

29/06/2021

EV Biotech joins EuropaBio: effective, bio-based alternatives to conventional chemical-synthetic production processes

23/06/2021

23/06/2021

Interview with… Dr. Jernej Pintar, CEO and Head of Tech Community at Technology Park Ljubljana

23/06/2021

23/06/2021

Technology Park Ljubljana joins EuropaBio: better world through better technology

16/06/2021

16/06/2021

EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines

14/06/2021

14/06/2021

European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation

14/06/2021

14/06/2021

Novartis is proud to support the EuropaBio 25th Anniversary

09/06/2021

09/06/2021

Interview with Cyrille Pauthenier, CEO of Abolis Biotechnologies – The Bio-Synthesis Architects

07/06/2021

07/06/2021

EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities

07/06/2021

07/06/2021

Pragmatic IP solutions and strong collaborations will ensure faster global access to vaccines

01/06/2021

01/06/2021

EFIB 2021 launch event: biotech community discussed innovation solutions for a sustainable future

31/05/2021

31/05/2021

EuropaBio Key Messages to 94th Pharmaceutical Committee – 28 May 2021

27/05/2021

27/05/2021

EuropaBio welcomes the EU strategy on Covid-19 therapeutics

27/05/2021

27/05/2021

EuropaBio meets EMA to exchange views on topics of common interest

26/05/2021

26/05/2021

Enabling NGT products to contribute to sustainability: The role of Industrial Biotechnology

26/05/2021

26/05/2021

Inter-association letter to the EU Ministers of Agriculture and DG SANTE

25/05/2021

25/05/2021

Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation

20/05/2021

20/05/2021

EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments

20/05/2021

20/05/2021

Decentralised clinical trials, the future of clinical research

20/05/2021

20/05/2021

Advanced Therapies bring tranformational value to European patients

19/05/2021

19/05/2021

EFIB 2021 ’Delivering the EU Green Deal: Industrial biotechnology into business’: Registration is Open

18/05/2021

18/05/2021

Interview with Bill Nankervis, Executive Vice President and Chief Operating Officer, Lallemand Group of Companies

18/05/2021

18/05/2021

Lallemand joins EuropaBio: new global opportunities for industrial biotechnology

12/05/2021

12/05/2021

EuropaBio celebrated its inaugural National Associations Council Summit: Collaborations and trust are vital to build a responsive and competetive biotech sector in Europe

12/05/2021

12/05/2021

Meatable joins EuropaBio: together towards a more sustainable food industry

12/05/2021

12/05/2021

Interview with… Krijn de Nood, Co-Founder & CEO at Meatable

07/05/2021

07/05/2021

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge

06/05/2021

06/05/2021

EU Industrial Strategy 2020: EuropaBio welcomes increased focus on competitiveness and resilience, driven by innovation and advanced technologies

05/05/2021

05/05/2021

EuropaBio comments on the designation of official laboratories for animal and plant health and safe food and feedstuffs

05/05/2021

05/05/2021

EuropaBio comments on the new EU soil strategy

05/05/2021

05/05/2021

EUBA Statement on Revised draft Delegated Act on climate-related objectives

04/05/2021

04/05/2021

Interview with… Juan Medina, Co-Founder & CEO at Kaffe Bueno

04/05/2021

04/05/2021

Kaffe Bueno joins EuropaBio: unlocking coffee’s therapeutic and industrial potential

03/05/2021

03/05/2021

EuropaBio launches a new Biopharmaceutical Strategy Group

29/04/2021

29/04/2021

EuropaBio on NGT study: A positive step towards delivering innovation

28/04/2021

28/04/2021

Interview with… Agne Vaitkeviciene, Executive Director of LBTA

28/04/2021

28/04/2021

The Lithuanian Biotechnology Association joins EuropaBio: it’s time to put Lithuania on a map of the most biotech savvy nations

27/04/2021

27/04/2021

EuropaBio proposes how to increase competitiveness of biotechnology sector in the EU

25/04/2021

25/04/2021

EuropaBio invited industrial biotech SMEs to learn about EU Policy Priorities

21/04/2021

21/04/2021

Interview with… Kristina Eskenazi, Chair of Health & Life Sciences Cluster Bulgaria

21/04/2021

21/04/2021

Health and Life Sciences Cluster Bulgaria joins EuropaBio: AI as enabler of biotech growth

16/04/2021

16/04/2021

Online Roundtable Report: An EU Vision For Life Science and Biotechnology for a Healthy and Sustainable EU

16/04/2021

16/04/2021

EuropaBio Response to the Public Consultation on Blood, tissues and cells for medical treatments & therapies

14/04/2021

14/04/2021

Interview with… Dr. Kim Domela Kjøller, CEO at UNION Therapeutics

14/04/2021

14/04/2021

UNION Therapeutics joins EuropaBio: building a pipeline for inflammation and infectious diseases

06/04/2021

06/04/2021

Interview with… Dr. Jim Lalonde, Head of Microbial Business Area at INSCRIPTA

06/04/2021

06/04/2021

Inscripta joins EuropaBio: delivering global biotechnology advances

31/03/2021

31/03/2021

EuropaBio response to the EGE report ‘Ethics of Genome Editing’

29/03/2021

29/03/2021

Abolis joins the EuropaBio 25th Anniversary in 2021

25/03/2021

25/03/2021

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key

22/03/2021

22/03/2021

EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe

15/03/2021

15/03/2021

Abolis joins EuropaBio: Sustainable Bio-Based Products

09/03/2021

09/03/2021

Catalent joins the EuropaBio 25th Anniversary in 2021

05/03/2021

05/03/2021

Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe

01/03/2021

01/03/2021

Rare Disease Week 2021 – Interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi

01/03/2021

01/03/2021

EuropaBio Celebrates 25 Years of Biotech Innovation with 2021 Anniversary Programme

24/02/2021

24/02/2021

European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback

15/02/2021

15/02/2021

The Business of Biotechnology: Growing for Europe’s tomorrow

12/02/2021

12/02/2021

EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion

12/02/2021

12/02/2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

04/02/2021

04/02/2021

EuropaBio draft response to the IIA on European Health Data Space

02/02/2021

02/02/2021

Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)

29/01/2021

29/01/2021

Building a European Health Union

28/01/2021

28/01/2021

European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation

20/01/2021

20/01/2021

Revision of the EU legislation on medicines for children and rare diseases

24/12/2020

24/12/2020

Joint Statement: Comitology Reform Threatens Innovation

20/12/2020

20/12/2020

EuropaBio Comments on the Draft Delegated Act on Climate-Related Objectives under the Taxonomy Regulation

30/11/2020

30/11/2020

Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms

25/11/2020

25/11/2020

An EU IP Action Plan for strong industrial ecosystems

25/11/2020

25/11/2020

EuropaBio Statement on the EU Pharmaceutical Strategy

10/11/2020

10/11/2020

Create sustainable bio-based and biodegradable plastics

02/11/2020

02/11/2020

EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association

20/10/2020

20/10/2020

EuropaBio on Use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making

19/10/2020

19/10/2020

Application of the ATMP Hospital Exemption in the EU

07/10/2020

07/10/2020

Nobel Prize for Genome Editing Pioneers

02/10/2020

02/10/2020

#EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference

30/09/2020

30/09/2020

EuropaBio Patient engagement with the European Medicines Agency

24/09/2020

24/09/2020

Genome editing FAQ

03/09/2020

03/09/2020

Novartis’s Andrew Topen appointed as new Chairman of EuropaBio

24/08/2020

24/08/2020

Genome-Edited Products and Projects: Resources and Examples

13/08/2020

13/08/2020

Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations

03/08/2020

03/08/2020

Joint Statement on the Health Innovation Partnership Proposal

30/07/2020

30/07/2020

Joint response of EuropaBio and BIO on the EU Data Strategy Consultation

30/07/2020

30/07/2020

EuropaBio response to the public consultation on the Roadmap for an EU Pharmaceutical Strategy

30/07/2020

30/07/2020

EuropaBio response to the Work Programme of the eHealth Stakeholder Group

15/07/2020

15/07/2020

EuropaBio position paper on the Farm to Fork Strategy

30/06/2020

30/06/2020

EuropaBio observations in response to Europe’s Beating Cancer Plan

22/06/2020

22/06/2020

EuropaBio position on the EU Biodiversity Strategy for 2030

19/06/2020

19/06/2020

ACCELERATE FAIR Initiative Letter of Support

17/06/2020

17/06/2020

EU-UK Future Relations – Joint Letter Life Sciences Coalition

26/05/2020

26/05/2020

Joint statement on the EU Climate Law

20/05/2020

20/05/2020

The impact of COVID-19 on patients with chronic or life-threatening conditions

20/05/2020

20/05/2020

EuropaBio position on Germline Genome Editing

20/05/2020

20/05/2020

EuropaBio highlights synergies between biotechnology and Farm to Fork and Biodiversity Strategy ambitions

30/04/2020

30/04/2020

How soon can we respond to COVID-19?

30/04/2020

30/04/2020

EuropaBio reply letter to European Patients’ Forum’s call on COVID-19

30/04/2020

30/04/2020

CRISPR and Coronavirus

30/04/2020

30/04/2020

Clinical Trials and Coronavirus

30/04/2020

30/04/2020

World Haemophilia Day – Interview with Amanda Bok (EHC)

29/04/2020

29/04/2020

European Bioeconomy Alliance (EUBA) Position on the EU Green Deal

28/04/2020

28/04/2020

Primary Immunodeficiencies Week – Interview Johan Prevot (IPOPI)

17/04/2020

17/04/2020

World Haemophilia Day – Interview with Dr. Ian Winburn (Pfizer)

17/04/2020

17/04/2020

World Haemophilia Day – A Message from Paul Perrault (CSL Behring)

17/04/2020

17/04/2020

World Haemophilia Week – Interview with Philip Wood (Sobi)

10/04/2020

10/04/2020

European Industry trade and supply chain needs to respond to Covid-19 – Joint Letter to the EU Trade Ministers

30/03/2020

30/03/2020

Biotechnology spearheads the fight against COVID-19

09/03/2020

09/03/2020

EuropaBio Position & Policy Recommendations to support EU ATMP Innovation

29/02/2020

29/02/2020

Strike Rare Diseases at the Root!

12/02/2020

12/02/2020

European Bioeconomy Alliance (EUBA) comments on the European Climate Law Roadmap

12/02/2020

12/02/2020

Industrial biotechnology solutions for sustainable agriculture

04/02/2020

04/02/2020

Let’s Beat Cancer with Innovation!

01/02/2020

01/02/2020

What if we used biology instead of chemistry for manufacturing?

30/01/2020

30/01/2020

A Vision for a EU Life Science and Biotechnology Strategy

26/01/2020

26/01/2020

What if we could definitively cure AIDS

25/01/2020

25/01/2020

Create immunotherapy treatments for cancer

25/01/2020

25/01/2020

Reduce the depletion of small fish in our oceans

20/01/2020

20/01/2020

EuropaBio comments on the Circular Economy Action Plan

20/01/2020

20/01/2020

What if we used algae to make biofuel?

15/01/2020

15/01/2020

Create ‘living drugs’ that treat cancer

15/01/2020

15/01/2020

What if we could heal sick blood cells

10/01/2020

10/01/2020

What if we could find new tools in the fight against cancer

09/01/2020

09/01/2020

Inter-association letter to the European Commission and Member States

05/01/2020

05/01/2020

What if we could transform wood into food preservatives?

01/01/2020

01/01/2020

What if we could prevent childhood blindness

30/11/2019

30/11/2019

EuropaBio position on Germline Genome Editing

10/10/2019

10/10/2019

EuropaBio Patients BioForum – Key Messages

10/10/2019

10/10/2019

Wealth of innovation on display & bio-based winners revealed at EFIB 2019 in Brussels

30/09/2019

30/09/2019

#EFIB2019 – EuropaBio hosts 12th annual Industrial Biotech and Bioeconomy Conference

26/09/2019

26/09/2019

Industrial Biotechnology – Enabling a Circular Bioeconomy in Europe

16/09/2019

16/09/2019

Joint Statement for an Ambitious Horizon Europe Programme

30/06/2019

30/06/2019

EuropaBio Healthcare Manifesto

25/06/2019

25/06/2019

Achieving the Potential of Genome Editing: the Perspective of the European Biotech Industry

03/06/2019

03/06/2019

Vision for a Circular Bio-Society

09/05/2019

09/05/2019

Open Letter to Member States on the EU Court Ruling on Mutagenesis

20/04/2019

20/04/2019

Joint Statement on Horizon Europe

28/02/2019

28/02/2019

EuropaBio Advanced Therapy

20/02/2019

20/02/2019

Export Manufacturing Waiver for Supplementary Protection Certificates: a red flag for investment in EU healthcare biotech

19/02/2019

19/02/2019

Advanced Medicinal Therapies – Step Up The Healthcare Revolution Now

20/12/2018

20/12/2018

Case Studies demonstrating Industrial Biotech contribution to UN SDGs

29/11/2018

29/11/2018

Statement: As EU court ruling risks blocking innovation, the European biotech industry calls for science-based political decision making on genome edited products

23/11/2018

23/11/2018

Joint Statement on HE and Partnerships

16/10/2018

16/10/2018

#EFIB2018 – Toulouse hosts 11th edition of leading Industrial Biotech Conference highlighting the breakthroughs and potential of the circular bioeconomy

11/10/2018

11/10/2018

EuropaBio welcomes renewed commitment to the EU Bioeconomy

29/06/2018

29/06/2018

Chemically Synthesized Proteins Referencing Biological Medicinal Products

28/06/2018

28/06/2018

Joint Pharmaceutical Industry Statement on the Commission’s Proposal for a Regulation on Health Technology Assessment (HTA)

25/06/2018

25/06/2018

Industrial biotechnology – Contributing towards achieving the UN global Sustainable Development Goals

28/05/2018

28/05/2018

SPC waiver risks downgrading the EU as a hub for Health Innovation

25/05/2018

25/05/2018

EFIB 2018 Registrations are now open

31/03/2018

31/03/2018

Statement in response to the EU Council ratifying the Brexit transition deal

31/03/2018

31/03/2018

European health community issues key questions Article 50 negotiations must answer for patients and public health

28/12/2017

28/12/2017

United Kingdom Exiting from EU – BREXIT. Life Sciences Industry CoalitionUK Exiting from EU – Life Sciences Industry Coalition

28/12/2017

28/12/2017

BREXIT Life Sciences Coalition – Joint Position Paper

29/11/2017

29/11/2017

European Commission launches: “What I need to know about Biosimilar Medicines – Information for patients”, in 23 EU languages

30/10/2017

30/10/2017

MetGen receives John Sime Award and Plantics becomes PitchFest winner at #EFIB2018

28/10/2017

28/10/2017

From Patent to Patient – The importance of IP rewards and incentives

27/09/2017

27/09/2017

Joint Press Release on ATMPs and GMOs in Europe

06/06/2017

06/06/2017

EuropaBio launches recommendations to enhance transparency of biosimilar labels

27/05/2017

27/05/2017

Biosimilar SmPC Recommendations

03/03/2017

03/03/2017

EuropaBio statement on European Parliament report on EU options for improving access to medicines

02/02/2017

02/02/2017

“Buying Innovative” in the Healthcare Biotech Market in Europe

23/01/2017

23/01/2017

European Commission Initiative Improves Information for Patients on Biosimilar Medicines

25/09/2016

25/09/2016

Jobs & Growth Generated by Industrial Biotechnology in Europe

26/10/2015

26/10/2015

Bioeconomy Factsheets

BIOTECH NEWSLETTER

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!

FOLLOW US HERE

Keep up with what is happening in the Biotech sector by connecting with us on social media!

BIOTECH NEWSLETTER

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!

Become a member